dacarbazine has been researched along with Duncan Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demir, I; Gunes, AK; Pehlivan, M | 1 |
| Liu, Y; Qu, W; Sun, LY; Wang, L; Wei, L; Yuan, LL; Zeng, ZG; Zhu, ZJ | 1 |
| Akashi, K; Asaoku, H; Ayano, M; Fujisaki, T; Harada, T; Iwasaki, H; Kato, K; Kohno, K; Mitoma, H; Miyamoto, T; Miyamura, T; Miyoshi, H; Mori, Y; Muta, T; Niiro, H; Ohshima, K; Oryoji, K; Oshiro, Y; Sakamoto, A; Sawabe, T; Takase, K; Takeshita, M; Urata, S; Yamamoto, H; Yoshimoto, G | 1 |
| Dhamija, R; Nelson, A; Nickels, K | 1 |
| Al-Katib, A; Jenkins, BD; Mohamed, A; Snower, D | 1 |
5 other study(ies) available for dacarbazine and Duncan Disease
| Article | Year |
|---|---|
Classical Hodgkin lymphoma-like post-transplant lymphoproliferative disease after allogeneic stem cell transplantation for primary myelofibrosis is successfully treated with nivolumab: A case report.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoproliferative Disorders; Nivolumab; Positron-Emission Tomography; Primary Myelofibrosis; Stem Cell Transplantation; Treatment Outcome; Vinblastine | 2021 |
Post-transplant lymphoproliferative disorder after paediatric liver transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Liver Transplantation; Lymphoproliferative Disorders; Retrospective Studies; Vinblastine | 2021 |
Outcomes of methotrexate-associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Rheumatoid; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Humans; Janus Kinases; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prednisone; Progression-Free Survival; Proportional Hazards Models; Rituximab; Treatment Outcome; Tumor Necrosis Factor-alpha; Vinblastine; Vincristine | 2021 |
Posttransplant lymphoproliferative disorder in an 11-year-old immunosuppressed boy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain; Child; Dacarbazine; Heart Transplantation; Humans; Hypesthesia; Immunosuppression Therapy; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Male; Methotrexate; Muscle Weakness; Rituximab; Temozolomide | 2013 |
Variant lymphoproliferative disorder of granular lymphocytes (LDGL) following Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chromosome Aberrations; Cytogenetic Analysis; Dacarbazine; Doxorubicin; Female; Granulocytes; Hodgkin Disease; Humans; Lymphocytosis; Lymphoproliferative Disorders; Neoplasm Staging; Phenotype; T-Lymphocytes; Vinblastine | 2005 |